Oppenheimer Maintains Outperform on Corbus Pharmaceuticals, Lowers Price Target to $52
Corbus Pharmaceuticals Holdings Inc CRBP
$8.26
▲ +2.61%
(+$0.21)
Open
$8.26
Prev Close
$8.05
Day Range
$8.02 – $8.47
52W Range
$6.72 – $20.56
Market Cap
$153.04M
Beta
2.62
EPS (TTM)
$-5.81
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-10-24 |
| Shares Out. | 18,530,000 |
| Website | corbuspharma.com/ ↗ |
| Phone | 16179630103 |
Corbus Pharmaceuticals Holdings Inc is a publicly traded company under the ticker symbol CRBP on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
16 analysts (2026-06-01)